LIVER DISEASES
Clinical trials for LIVER DISEASES explained in plain language.
Never miss a new study
Get alerted when new LIVER DISEASES trials appear
Sign up with your email to follow new studies for LIVER DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to tame dangerous liver pressure
Disease control TerminatedThis study tested if a new drug called Avenciguat, taken alone or with an existing diabetes drug (empagliflozin), could reduce high blood pressure in the main vein leading to the liver. It involved 90 adults with liver cirrhosis from hepatitis B, hepatitis C, or fatty liver disea…
Matched conditions: LIVER DISEASES
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Massive study tracks 1,700 hepatitis b patients to map disease journey
Knowledge-focused TerminatedThis study observed 1,708 adults with chronic hepatitis B across US and Canadian clinics to understand how the disease progresses and how treatments work in real-world settings. Researchers collected information about patients' treatments, health outcomes, and side effects withou…
Matched conditions: LIVER DISEASES
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC